AML Video Channel
Explore the latest insights and summaries from experts in AML.
Diagnostics & Biomarkers
SOHO Brazil 2024
Understanding the NPM1 Mutation in AML: Dr. Jekyll and Mr. Hyde
FEATURING
Jeffrey Lancet
- 530 views
- July 11, 2024
- 2
Moffitt Cancer Center
Using Transplant in Patients With p53 Mutant MDS or AML
FEATURING
Hany Elmariah
- 329 views
- March 7, 2024
- 5
University of Miami Sylvester Comprehensive Cancer Center
Role of Mutations in AML: FLT3-ITD Mutation Confers Poor Prognosis but is Actionable
FEATURING
Sangeetha Venugopal
- 185 views
- March 18, 2024
- 1
UChicago Medicine 12th International Clinical Cancer Genomics Conference
MDS and AML: Implementation of Guideline-Driven Germline Genetic Evaluation Criteria
FEATURING
Lauren Banaszak
- 399 views
- May 28, 2024
- 4
Icahn School of Medicine at Mount Sinai
BPDCN: Current and Future Directions
FEATURING
Naveen Pemmaraju
- 488 views
- May 31, 2024
- 2
SOHO Highlights: State of the Art and Next Questions
State of the Art and Next Questions: AML
FEATURING
Farhad Ravandi
- 384 views
- March 25, 2024
- 2
i3 Health
MRD Testing in Leukemias: When Negativity Is a Positive Thing
FEATURING
Noopur S. Raje
- 476 views
- March 15, 2024
- 1
Jesse Hirner
BPDCN: A Dermatologist's Perspective on Differential Diagnosis
- 1,656 views
- August 16, 2024
- 10
Rush University Medical Center
What is New in AML: Risk Classification, Germline Mutations, and Targeted Therapies
FEATURING
Ehab Atallah
- 231 views
- May 29, 2024
- 1
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient
Use and Interpretation of Molecular Genetics in Blood Cancer
FEATURING
Jennifer Morrissette
- 350 views
- March 4, 2024
- 2
MyCancerHaven
Experts Discuss the Pathophysiology, Diagnosis, and Treatment of BPDCN
FEATURING
Ravi Vij,
Guru Murthy
- 608 views
- August 30, 2024
- 3
MyCancerHaven
Experts Discuss How to Approach Frontline Treatment of Unfit Patients With AML
- 105 views
- May 22, 2024
Talha Badar
Challenges in the Management of TP53-Mutated AML: Potential Strategies to Improve Outcomes
- 452 views
- March 5, 2024
- 3
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Practical Approach to MRD Monitoring in AML: Assessing Treatment Efficacy and Relapse Risk
FEATURING
Tapan Kadia
- 104 views
- September 11, 2024
Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course
AML: Diagnosis, Trends, and Approaches
FEATURING
Mary-Beth Percival
- 82 views
- August 14, 2024
Icahn School of Medicine at Mount Sinai
Therapeutic Targeting of RNA Splicing Factor Mutant Leukemias
FEATURING
Omar Abdel-Wahab
- 57 views
- July 2, 2024
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Acute Promyelocytic Leukemia: Risk Stratification and New Treatment Modalities
FEATURING
Suar ÇAkı Kılıç
- 83 views
- February 16, 2024
- 1
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Pediatric AML: Diagnosis and Risk Stratification
FEATURING
Nihal Karadaş
- 179 views
- February 16, 2024